{"title":"Comparison of two techniques of steroid injections in the management of Frozen shoulder","authors":"S. Upadhyay, S. Singh, A. Varshney","doi":"10.17511/ijoso.2021.i03.04","DOIUrl":null,"url":null,"abstract":"Background: Frozen shoulder is a condition in which movement of the shoulder becomes restricted.It can be described as either primary (idiopathic) whereby the aetiology is unknown, or secondary,when it can be attributed to another cause. It is commonly a self-limiting condition, of approximately1 to 3 years' duration, though incomplete resolution can occur. The aetiology of shoulder pain isdiverse and includes pathology originating from the neck, glenohumeral joint, acromioclavicularjoint, rotator cuff, and other soft tissues around the shoulder girdle. The most common source ofshoulder pain is the rotator cuff, accounting for over two-thirds of cases. Material and methods:This was a prospective study with 50 patients coming to our OPD. Patients of all stages wereincluded and randomized into two groups. Group 1: Single Site Injection (SSI) group receivedsteroid injection through posterior approach and Group 2: Novel three-site ( NTS )group receivedthe same dose of steroid in diluted doses at three sites (posterior capsule, subacromial andsubcoracoid). The second sitting was repeated after 3 weeks. Both groups had received the samephysiotherapy. The patients were evaluated by the CONSTANT score at initial, 3 weeks, 6 weeks and6 months. Results: Patients of Group 2 (NTS group) had significant pain relief and earlyimprovement in activities of daily living (p < 0.005) as compared to Group 1 (SSI Group). Also,although there was an improvement in shoulder movements in both the groups but in Group 2 (NTS)patients, early near-normal scores were attained and sustained even after 6 months. About 40% inGroup 1 (SSI) could not attain near-normal levels and had relapses. Conclusion: The Novel three-site approach of steroid injections in frozen shoulder provides early recovery, better pain relief andbetter improvement in shoulder function with fewer relapses.","PeriodicalId":267909,"journal":{"name":"Surgical Update: International Journal of Surgery and Orthopedics","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Update: International Journal of Surgery and Orthopedics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17511/ijoso.2021.i03.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Frozen shoulder is a condition in which movement of the shoulder becomes restricted.It can be described as either primary (idiopathic) whereby the aetiology is unknown, or secondary,when it can be attributed to another cause. It is commonly a self-limiting condition, of approximately1 to 3 years' duration, though incomplete resolution can occur. The aetiology of shoulder pain isdiverse and includes pathology originating from the neck, glenohumeral joint, acromioclavicularjoint, rotator cuff, and other soft tissues around the shoulder girdle. The most common source ofshoulder pain is the rotator cuff, accounting for over two-thirds of cases. Material and methods:This was a prospective study with 50 patients coming to our OPD. Patients of all stages wereincluded and randomized into two groups. Group 1: Single Site Injection (SSI) group receivedsteroid injection through posterior approach and Group 2: Novel three-site ( NTS )group receivedthe same dose of steroid in diluted doses at three sites (posterior capsule, subacromial andsubcoracoid). The second sitting was repeated after 3 weeks. Both groups had received the samephysiotherapy. The patients were evaluated by the CONSTANT score at initial, 3 weeks, 6 weeks and6 months. Results: Patients of Group 2 (NTS group) had significant pain relief and earlyimprovement in activities of daily living (p < 0.005) as compared to Group 1 (SSI Group). Also,although there was an improvement in shoulder movements in both the groups but in Group 2 (NTS)patients, early near-normal scores were attained and sustained even after 6 months. About 40% inGroup 1 (SSI) could not attain near-normal levels and had relapses. Conclusion: The Novel three-site approach of steroid injections in frozen shoulder provides early recovery, better pain relief andbetter improvement in shoulder function with fewer relapses.